New findings from the NIH RECOVER Initiative suggest that SARS-CoV-2 infection may be associated with an increased risk of ME ...

By Dr. Liji Thomas, MD Study reveals how the JAK inhibitor lowers ACE2 expression and viral entry in individuals with a ...

Adriel Chen and Devi Sridhar discuss the outbreak of Paediatric Inflammatory Multisystem Syndrome in 2020 and consider what lessons we can learn In mid-March 2020 and into April 2020, paediatric wards ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

Jake Sullivan, the outgoing national security adviser, is asking a panel of outside experts to examine the government’s ...

A recent University of Utah Health study found that 4.5% of Covid-19 survivors developed chronic fatigue syndrome, a ...

Levels of respiratory illnesses in the Sheboygan area are high, on trend with regional and state data, according to Sheboygan ...

Today the Centers for Disease Control and Prevention (CDC) in its weekly FluView update, confirmed 11 new pediatric deaths ...

A sign warns people to stay out of forest on a tract of privately owned land in 2024 near Alsea. A record 1.9 million acres ...

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...